Trial Details
COMPLETEDBasic Information
| Clinical ID | c2284 |
|---|---|
| Identifier | NCT03733314 |
| Trial Title | A Study of E6011 in Participants With Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: E6011|DRUG: Placebo |
Participant Information
| Sponsor | EA Pharma Co., Ltd. |
|---|---|
| City | Ostrava |
| Country/Region | Czechia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-04-25 |
|---|---|
| Primary Completion Date | 2022-03-16 |
| Completion Date | 2024-04-03 |